Drug Research
Startups Tackle Efficiency Woes In The Pharma Supply Chain
The healthcare industry is responsible for 4.4% of all greenhouse gas emissions and faces significant challenges in its supply chain, resulting in $35 billion worth of wasted products each year. Startups have emerged as powerful agents of change, leveraging...
Drug Research
Pharma Supply Chains: From Globalization To Regional Hubs
Overseeing a pharmaceutical supply chain and ensuring its efficiency is a complex and collaborative endeavor. The process commences with sourcing raw materials, including chemicals and ingredients, which are used to manufacture drugs. These drugs undergo stringent quality checks, formulation,...
Drug Research
UHPT Method In NMR Benefits Natural Product Bio Industry
In the late 1950s and 1960s, thalidomide, a drug given to pregnant women to alleviate morning sickness, caused a tragic outcome. Over 12,000 babies were born with severe malformations, like shortened limbs, due to the drug's side effects. These...
Drug Research
Upperton completes build of new £15m development and GMP manufacturing facility
Leading UK contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has completed the build of its new development and GMP manufacturing headquarters in Nottingham, UK.
Situated less than two miles from Upperton’s current HQ, the facility houses ten new...
BioPharma
Overcoming Treatment Challenges With Cell And Gene Therapies
Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with traditional medicine. These therapies involve introducing, replacing, or deactivating genes in cells, either inside or...
Drug Research
Innovative Antibody Creation Requires An Apt CDMO Choice
Making the right contract development and manufacturing choice happens to be a pivotal decision for biopharmaceutical firms that happen to be embarking on projects pertaining to novel antibody development.
With the sector’s rising demand when it comes to qualified multidisciplinary...
BioPharma
Boosting Innovation And Value In UK Biopharma And Medtech
New recommendations from Imperial College London aim to boost competitiveness in the UK's biopharma and Medtech sectors. It assesses the value-added per capita in these sectors and provides insights into their needs, challenges, and opportunities. Technological solutions and policy...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















